Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Aventis (NYSE:AVE)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Options
Location
67917 Strasbourg, Cedex 9
Strasbourg 67917, France
Phone: (917) 965-1412
Email: n.hunt@aventis.com
Employees (last reported count): 102,489
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Subsidiaries
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 15%
·Institutional: 3% (3% of float)
(203 institutions)
·Net Inst. Selling: 2.82M shares (+15.81%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Aventis S.A. is a world leader in life sciences. Focused on two core business areas - pharmaceuticals and agriculture - Aventis is dedicated to improving life through the discovery and development of innovative products in the fields of prescription drugs, vaccines, therapeutic proteins, crop production and protection, animal health and nutrition. With global corporate headquarters in Strasbourg, France, Aventis employs around 95,000 people in more than 120 countries. Aventis was launched in December 1999 through the merger of Hoechst AG of Germany and Rhone-Poulenc S.A of France.
More from Market Guide: Expanded Business Description

Financial Summary
Aventis is engaged in the research, development, production, marketing and sale of organic and inorganic intermediate chemicals, specialty chemicals, fibers, polymers, pharmaceuticals and agricultural chemicals. For the six months ended 6/01, net sales rose 5% to EUR11.65 billion. Net income applicable to Common before U.S. GAAP totalled EUR730M, up from EUR337M. Results reflect increased sales of prescription drugs, and decreased restructuring costs.
More from Market Guide: Significant Developments

Officers

Position
Jurgen DormannChairman of Management
Jean-Rene Fourtou, 59Vice Chairman of Management
Igor Landau, 54Member of the Board of Management
Horst WaescheMember of the Board of Management
Patrick Langlois, 53Group Exec. VP, CFO
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:AVEAs of 31-Aug-2001
Price and Volume
52-Week Low
on 12-Oct-2000
$66.625
Recent Price$73.00 
52-Week High
on 29-Dec-2000
$87.50 
Beta0.39 
Daily Volume (3-month avg)110.1K
Daily Volume (10-day avg)81.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-3.2%
52-Week Change
relative to S&P500
+29.8%
Share-Related Items
Market Capitalization$57.4B
Shares Outstanding785.9M
Float668.0M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$13.42 
Earnings (ttm)$0.28 
Earnings (mrq)$0.48 
Sales (ttm)$26.55 
CashN/A 
Valuation Ratios
Price/Book (mrq)5.44 
Price/Earnings (ttm)258.87 
Price/Sales (ttm)2.75 
Income Statements
Sales (ttm)$20.8B
EBITDA (ttm)$2.05B
Income available to common (ttm)$223.9M
Profitability
Profit Margin (ttm)1.6%
Operating Margin (ttm)6.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)0.89%
Return on Equity (ttm)2.12%
Financial Strength
Current Ratio (mrq)0.92 
Debt/Equity (mrq)1.10 
Total CashN/A 
Short Interest
As of 8-Aug-2001
Shares Short376.0K
Percent of Float0.1%
Shares Short
(Prior Month)
645.0K
Short Ratio3.55 
Daily Volume106.0K
ADR Information
Shares/ADR1
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001);   dollar amounts based on an exchange rate of 1.1 Euro/Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.